A Safety and Efficacy Study of SHR4640 and Febuxostat in Subjects With Hyperuricemia
Clinical trial NCT04180982 · UNKNOWN
Trial details
- NCT number
- NCT04180982
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-03
- Primary completion
- 2020-07-30
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.